Penumbra Revenue 2014-2022 | PEN
Penumbra annual/quarterly revenue history and growth rate from 2014 to 2022. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Penumbra revenue for the quarter ending June 30, 2022 was $0.208B, a 13.07% increase year-over-year.
- Penumbra revenue for the twelve months ending June 30, 2022 was $0.806B, a 20.1% increase year-over-year.
- Penumbra annual revenue for 2021 was $0.748B, a 33.4% increase from 2020.
- Penumbra annual revenue for 2020 was $0.56B, a 2.38% increase from 2019.
- Penumbra annual revenue for 2019 was $0.547B, a 23.03% increase from 2018.
Penumbra Annual Revenue
(Millions of US $) |
| 2021 |
$748 |
| 2020 |
$560 |
| 2019 |
$547 |
| 2018 |
$445 |
| 2017 |
$334 |
| 2016 |
$263 |
| 2015 |
$186 |
| 2014 |
$126 |
| 2013 |
$89 |
Penumbra Quarterly Revenue
(Millions of US $) |
| 2022-06-30 |
$208 |
| 2022-03-31 |
$204 |
| 2021-12-31 |
$204 |
| 2021-09-30 |
$190 |
| 2021-06-30 |
$184 |
| 2021-03-31 |
$169 |
| 2020-12-31 |
$167 |
| 2020-09-30 |
$151 |
| 2020-06-30 |
$105 |
| 2020-03-31 |
$137 |
| 2019-12-31 |
$145 |
| 2019-09-30 |
$140 |
| 2019-06-30 |
$134 |
| 2019-03-31 |
$128 |
| 2018-12-31 |
$121 |
| 2018-09-30 |
$112 |
| 2018-06-30 |
$110 |
| 2018-03-31 |
$103 |
| 2017-12-31 |
$96 |
| 2017-09-30 |
$84 |
| 2017-06-30 |
$81 |
| 2017-03-31 |
$73 |
| 2016-12-31 |
$73 |
| 2016-09-30 |
$67 |
| 2016-06-30 |
$65 |
| 2016-03-31 |
$58 |
| 2015-12-31 |
$54 |
| 2015-09-30 |
$50 |
| 2015-06-30 |
$42 |
| 2015-03-31 |
$39 |
| 2014-12-31 |
|
| 2014-09-30 |
$32 |
| 2013-12-31 |
|
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical Instruments Manufacturing |
$6.042B |
$0.748B |
|
Penumbra, Inc. is an interventional therapies company. It designs, develops, manufactures and markets medical devices. The company's portfolio of products primarily addresses neuro and peripheral vascular medical conditions and clinical needs. Neuro products include Neurovascular Access, Neuron Access System, BENCHMARK Intracranial Access System, Penumbra System, 3D, Penumbra Coil 400, Penumbra SMART Coil and LIBERTY stent. Peripheral vascular products include Ruby Coil System, Penumbra Occlusion Device and Indigo System. It operates primarily in U.S., Europe, Canada and Australia. Penumbra, Inc. is headquartered in Alameda, California.
|
